Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis.
Grayling
M
M
Shackleton Department of Anaesthesia, Southampton General Hospital, Southampton, United Kingdom. mgrayling@doctors.org.uk
Deakin
C D
CD
D000368:Aged; D001022:Aortic Valve Insufficiency / Q000209:etiology; D001784:Blood Gas Analysis; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D017548:Echocardiography, Transesophageal; D004697:Endocarditis, Bacterial / Q000150:complications / Q000175:diagnosis / Q000378:metabolism / Q000601:surgery*; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors* / Q000502:physiology; D006801:Humans; D007022:Hypotension / Q000188:drug therapy* / Q000209:etiology*; D007249:Inflammation; D008297:Male; D008751:Methylene Blue / Q000494:pharmacology / Q000627:therapeutic use*; D008944:Mitral Valve Insufficiency / Q000209:etiology; D009569:Nitric Oxide / Q000502:physiology
D002316:Cardiotonic Agents; D009569:Nitric Oxide; D006162:Guanylate Cyclase; D008751:Methylene Blue; D004298:Dopamine